ArticleJournal of anesthesia2026
Two‑stage diphenhydramine improves early recovery in women after video‑assisted thoracoscopic surgery: a randomized controlled trial.
Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reply to Comments on "Two-stage diphenhydramine improves early recovery in women after video-assisted thoracoscopic surgery: a randomized controlled trial".Journal of anesthesia · 2026Article
- Comments on "Two-stage diphenhydramine improves early recovery in women after video-assisted thoracoscopic surgery: a randomized controlled trial" by Yin et al.Journal of anesthesia · 2026Article
- Comments on "Two-stage diphenhydramine improves early recovery in women after video-assisted thoracoscopic surgery: a randomized controlled trial".Journal of anesthesia · 2026Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
purposeThoracic paravertebral block (TPVB) provides effective analgesia for video-assisted thoracoscopic surgery (VATS). However, even when pain is well-controlled by TPVB, female patients remain at high risk for postoperative nausea and vomiting (PONV) and sleep disturbances because of non-analgesic factors, such as hormonal and central emetic pathways. We investigated whether adding a two-stage diphenhydramine regimen to TPVB-based multimodal analgesia improves early recovery quality.
methodsIn this prospective, randomized, double-blind, placebo-controlled trial, 80 women (ASA I-III) scheduled for elective VATS pulmonary resection were randomized to receive a two-stage diphenhydramine regimen (0.2 mg/kg bolus at chest closure followed by 0.5 mg/kg via postoperative patient-controlled intravenous analgesia [PCIA]) or placebo (normal saline). All patients received standardized TPVB with 20 mL 0.4% ropivacaine, PCIA with sufentanil/ondansetron, and intravenous dexamethasone 10 mg. The primary outcome was the 24-h Quality of Recovery-15 (QoR-15) score. Secondary outcomes included sleep quality, PONV incidence, pain scores, rescue medication requirements, and adverse events.
resultsThe diphenhydramine group exhibited a significantly higher median 24 h QoR-15 score (127 [IQR 121-134.75] vs. placebo 119.5 [IQR 108.25-130.75], P = 0.033). This group also demonstrated markedly better sleep quality (lower Athens Insomnia Scale scores at 24 and 48 h, P < 0.05) and a significantly reduced incidence of vomiting (10% vs. 40%, P = 0.004). Overall PONV rates and other secondary outcomes were comparable, with no difference in adverse events.
conclusionsAdding a two-stage diphenhydramine regimen to TPVB-based multimodal analgesia significantly improves early recovery quality, enhances postoperative sleep, and reduces vomiting in women after VATS, without increasing adverse events. CLINICAL
trial registrationChinese Clinical Trial Registry (ChiCTR2500097837).
Indexed as
Identifiers
42070219What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.